Cannabinol is a dibenzopyran.
How much products actually contain
No product states its amount yet.
Of the products containing it, 0 list it before the 1% line and 1 after it (usually 1% or less).
Products using this ingredient
1 of 1 confirmed · likeliest to carry enough first
Definition
Cannabinol is a dibenzopyran.
Source: PubChem
US FDA substance register · UNII 7UYP6MC9GH · registered name Cannabinol · single chemical substance
Cannabinol is the organic compound that conforms to the formula:
Cosmetic roles
Safety & regulatory references
- Banned
- Canada
Source: Health Canada Cosmetic Ingredient Hotlist
Health Canada Cosmetic Ingredient Hotlist · prohibited in cosmetics
Restriction II/306 CANNABINOL, as such, is not listed in the Schedules of the 1961 Single Convention on Narcotic Drugs. However, it shall be prohibited from use in cosmetic products (II/306), if prepared from a substance controlled in Schedule I of the 1961 Single Convention on Narcotic Drugs. Please note that national legislations on controlled substances may also apply.
Source: EU CosIng ingredient list
More data — names, identifiers, properties, test records, literature
Official labels & definitions
JCIA labelling name カンナビノール: 本品は、次の化学式で表される有機化合物である。
Source: JCIA labelling names (Japan)
Names & identifiers
- CAS No.chemical registry number
- 521-35-7
- EC No.EU chemical inventory number
- 689-788-0
- DTXSIDUS EPA chemical ID
- DTXSID3048996
- DTXCIDUS EPA compound ID
- DTXCID3028922
- IUPAC
- 6,6,9-Trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
- Molecular formula
- C21H26O2
- Molecular weight
- 310.437 g/mol
Measured properties
- Appearance
- Leaflets. (NTP, 1992)
- Boiling point
- 365 °F at 0.05 mmHg (NTP, 1992)
- Melting point
- 169 to 171 °F (NTP, 1992)
Values measured on the substance itself, not a specification for a commercial raw material.
Source: PubChem
Related literature
- From Analytical Profiling to Liposomal Delivery: Cannabinol as a Model for Antioxidant Encapsulation and Diffusion Enhancement · 2025
- Skin-Whitening Effects of Cannabinol (CBN) Through Melanin Inhibition in B16F10 Melanoma Cells · 2025
- In silico assessment of cannabinoids and related compounds as multi-target modulators of IL-2, TNF-α, HSP70/HSP90, EGF signaling, and MMP-2/MMP-9 in ovarian cancer · 2025
- Development of Paper-based Microfluidic Devices for the Detection of Cannabis Components · 2025
- Cannabinol modulates the endocannabinoid system and shows TRPV1‐mediated anti‐inflammatory properties in human keratinocytes · 2024
Linked databases 16
- ChEBI
- ChEMBL
- EU CosIng ingredient list 2
- Health Canada Cosmetic Ingredient Hotlist
- JCIA labelling names (Japan)
- MFDS (Korea) cosmetic regulatory information 2
- NIST Chemistry WebBook
- PubChem 2
- Tlooto literature search 2 3 4 5
- UniChem cross-reference IDs
- US EPA CompTox dashboard
- US EPA DSSTox chemical database
- US FDA substance registration (GSRS)
- US FDA Unique Ingredient Identifier (UNII)
- Wikidata
- Wikipedia · English · Japanese